	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	356	373	411	801	926	1,081	1,244	1,630	1,749
Cost of Operating Revenue	298	301	323	625	716	772	876	1,156	1,182
Gross Profit	58	73	87	175	210	309	367	474	568
Gross Margin	16.3	19.5	21.2	21.9	22.7	28.6	29.5	29.1	32.4
Total Operating Expenses	326	332	362	712	831	949	1,082	1,443	1,536
Operating Profit	30	41	49	89	96	132	161	187	214
Operating Margin	8.5	10.9	11.9	11.1	10.3	12.2	13.0	11.5	12.2
Financing Income/(Expense) - Net	-6	-3	-3	-4	-9	-7	6	-2	-18
Profit before Taxes	25	38	46	86	92	130	171	188	205
Income Taxes	5	10	12	22	24	35	43	47	51
Profit after Tax	20	28	35	64	68	94	128	141	154
PAT Margin	5.6	7.5	8.4	8.0	7.3	8.7	10.3	8.6	8.8
EPS - Basic - ex Extraordinary Items	4.14	5.81	7.19	13.32	14.16	18.66	22.41	24.63	26.92
EPS - Diluted - ex Extraordinary Items	4.14	5.81	7.19	13.32	14.16	18.66	22.41	24.63	26.92
EBIT	30	41	49	89	96	132	161	187	214
EBITDA	41	51	54	96	107	148	186	232	259
EBITDA Margin	11.5	13.6	13.3	12.0	11.5	13.7	15.0	14.2	14.8

Balance Sheet

Abridged

Understanding Balance Sheet

Innova Captab Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	PR	PR	PR	AR	AR	AR	AR	AR
Total Current Assets	143	171	270	379	442	580	696	923
Long-Term Investments	-	-	-	1	0	0	6	37
Property Plant & Equipment - Net	78	73	86	166	187	681	835	839
Total Non-Current Assets	80	74	99	196	262	741	885	914
Total Assets	223	245	370	575	704	1,321	1,580	1,837
Total Current Liabilities	112	120	215	295	278	265	353	495
Long Term Debt	26	12	6	68	136	211	245	216
Total Non-Current Liabilities	28	14	10	72	150	225	268	252
Total Liabilities	140	135	225	367	428	490	621	747
Total Shareholders' Equity	82	110	145	209	277	831	959	1,091
Total Equity	82	110	145	209	277	831	959	1,091
Total Liabilities & Equity	223	245	370	575	704	1,321	1,580	1,837

Cash Flow

Abridged

Understanding Cash Flow Statement

Innova Captab Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	26.95	38.24	39.30	74.92	86.30	126.61	180.73	205.82
Working Capital - Increase/(Decrease)	-13.28	-11.99	-1.14	-21.27	-31.06	7.31	-114.75	-103.13
Net CF from Operating Activities	13.67	26.24	38.16	53.65	55.24	133.93	65.98	102.69
Capital Expenditures - Net	8.11	4.23	18.45	79.80	78.25	287.25	172.24	61.32
Net CF from Investing Activities	-9.18	-6.10	-19.74	-189.10	-91.31	-501.50	-155.49	-109.88
Dividends Paid - Cash - Total	-	-	-	-	-	-	-	11.44
Stock - Issuance/(Retirement) - Net	-	-	-	-	50.00	323.11	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	-3.94	-18.66	-15.86	130.57	-10.55	52.67	93.30	6.31
Net Cash Flow from Financing Activities	-3.94	-18.66	-15.86	130.57	39.45	375.78	93.30	-5.13
Free Cash Flow to Equity	1.62	3.35	3.85	104.42	-33.57	-100.65	-12.96	47.69
Free Operating CF net dividend	5.56	22.01	19.43	-26.23	-23.75	-153.43	-106.51	22.90
Free Operating CF	5.56	22.01	19.43	-26.23	-23.75	-153.43	-106.51	34.34

Business Segment Analysis

FY End:

Mar 26

Innova Captab Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Drugs and Pharmaceutical (100.0%)₹ 68.35 Cr

Revenue / Sales

Drugs and Pharmaceutical (100.0%)₹ 1,630.02 Cr

Assets

Drugs and Pharmaceutical (100.0%)₹ 1,837.38 Cr

Operating Income

Drugs and Pharmaceutical (100.0%)₹ 186.84 Cr

Regional Segment Analysis

FY End:

Mar 26

Innova Captab Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

India (68.7%)₹ 1,101.39 CrOutside India (31.3%)₹ 502.51 Cr

Historical Segment Analysis

Track how Innova Captab Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2019 Mar 31	2020 Mar 31	2021 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2019 Mar 31	2020 Mar 31	2021 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Drugs and Pharmaceutical	8	4	19	79	287	172	68

Frequently Asked Questions

What is the revenue of Innova Captab Ltd.?

The latest trailing twelve month revenue of Innova Captab Ltd. is ₹ 1,749.33 Cr, reflecting a 1-year growth of 34.47% and a 3-year CAGR of 20.73%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Innova Captab Ltd.?

The latest trailing twelve month net profit (PAT) of Innova Captab Ltd. is ₹ 154.03 Cr, with a 3-year earnings CAGR of 20.26%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Innova Captab Ltd.?

The trailing twelve month EBITDA of Innova Captab Ltd. is approximately ₹ 213.62 Cr (based on an operating margin of 12.21%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Innova Captab Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Innova Captab Ltd. is 26.92. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Innova Captab Ltd.?

The debt-to-equity ratio of Innova Captab Ltd. stands at 0.32. The interest coverage ratio is 11.57x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Innova Captab Ltd.?

The estimated book value per share of Innova Captab Ltd. is 189.98 (derived from a P/B ratio of 5.46 and market price of ₹ 1,036.95), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Innova Captab Ltd.?

The trailing twelve month operating cash flow of Innova Captab Ltd. is ₹ 102.69 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Innova Captab Ltd. report consolidated or standalone financials?

Innova Captab Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.